Propanc Biopharma Inc
General ticker "PPCB" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $159.6K
Propanc Biopharma Inc does not follow the US Stock Market performance with the rate: -35.8%.
Estimated limits based on current volatility of 16.1%: low 0.00$, high 0.00$
Short-term PPCB quotes
Long-term PPCB plot
Financial data
| YTD | 2022-06-30 | 2023-06-30 | 2024-06-30 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $1.99MM | $1.78MM | $1.54MM |
| Operating Income | $-1.99MM | $-1.78MM | $-1.54MM |
| Non-Operating Income | $-0.72MM | $-1.01MM | $-0.41MM |
| Interest Expense | $0.57MM | $0.53MM | $0.67MM |
| R&D Expense | $0.26MM | $0.25MM | $0.25MM |
| Income(Loss) | $-2.71MM | $-2.79MM | $-1.95MM |
| Taxes | $-0.05MM | $-0.13MM | $-0.13MM |
| Profit(Loss) | $-2.66MM | $-2.66MM | $-1.82MM |
| Stockholders Equity | $-3.02MM | $-3.12MM | $-3.78MM |
| Assets | $0.08MM | $0.06MM | $0.07MM |
| Operating Cash Flow | $-1.44MM | $-1.11MM | $-0.94MM |
| Capital expenditure | $0.00MM | $0.00MM | $0.00MM |
| Investing Cash Flow | $-0.05MM | $-0.00MM | $0.00MM |
| Financing Cash Flow | $1.49MM | $1.11MM | $0.94MM |
| Earnings Per Share* | $-49.23 | $-1.80 | $-0.02 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.